» Articles » PMID: 25485941

Vascular Biomarkers and Correlation with Peripheral Vasculopathy in Systemic Sclerosis

Overview
Journal Autoimmun Rev
Publisher Elsevier
Date 2014 Dec 9
PMID 25485941
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular disease is a hallmark of systemic sclerosis (SSc). It is present in every patient, being responsible both for the earliest clinical manifestations and the major life-threatening complications of the disease, and thus determining important morbidity and mortality. In SSc, progressive vascular injury leads to vascular tone dysfunction and reduced capillary blood flow, with consequent tissue ischemia and chronic hypoxia. These phenomena are often accompanied by abnormal levels of vascular factors. Microangiopathy in SSc may be easily assessed by nailfold videocapillaroscopy. The variety of derangements detected in the nailfold capillaries is accompanied by abnormal levels of different vascular mediators and appears to be the best evaluable predictor of the development of peripheral vascular complications, such as digital ulcers. The purpose of this review is to summarize in SSc the most relevant vascular biomarkers and the main associations between vascular biomarkers and capillaroscopic parameters and/or the presence of digital ulcers. Vascular biomarkers could become useful predictive factors of vascular damage in SSc, allowing an earlier management of vascular complications.

Citing Articles

Neurological, cardiac, musculoskeletal, and renal manifestations of scleroderma along with insights into its genetics, pathophysiology, diagnostic, and therapeutic updates.

Prajjwal P, Marsool M, Yadav V, Kanagala R, Reddy Y, John J Health Sci Rep. 2024; 7(4):e2072.

PMID: 38660003 PMC: 11040569. DOI: 10.1002/hsr2.2072.


Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.

Muruganandam M, Ariza-Hutchinson A, Patel R, Sibbitt Jr W J Inflamm Res. 2023; 16:4633-4660.

PMID: 37868834 PMC: 10590076. DOI: 10.2147/JIR.S379815.


Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review.

Fioretto B, Rosa I, Matucci-Cerinic M, Romano E, Manetti M Int J Mol Sci. 2023; 24(4).

PMID: 36835506 PMC: 9965592. DOI: 10.3390/ijms24044097.


Novel therapies and innovation for systemic sclerosis skin ulceration.

Frech T, Frech M, Saknite I, OConnell K, Ghosh S, Baba J Best Pract Res Clin Rheumatol. 2023; 36(4):101813.

PMID: 36609122 PMC: 11671032. DOI: 10.1016/j.berh.2022.101813.


The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis.

Colasanti T, Stefanantoni K, Fantini C, Corinaldesi C, Vasile M, Marampon F Int J Mol Sci. 2022; 23(17).

PMID: 36077548 PMC: 9456348. DOI: 10.3390/ijms231710150.